way 100135 has been researched along with mdl 100907 in 2 studies
| Studies (way 100135) | Trials (way 100135) | Recent Studies (post-2010) (way 100135) | Studies (mdl 100907) | Trials (mdl 100907) | Recent Studies (post-2010) (mdl 100907) |
|---|---|---|---|---|---|
| 143 | 0 | 34 | 1,241 | 65 | 539 |
| Protein | Taxonomy | way 100135 (IC50) | mdl 100907 (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0048 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abu-Amara, M; Aldairy, C; Hagan, JJ; Siddiqui, A; Wilson, C | 1 |
| Eckler, JR; Rabin, RA; Rice, KC; Winter, JC | 1 |
2 other study(ies) available for way 100135 and mdl 100907
| Article | Year |
|---|---|
5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Female; Luteinizing Hormone; Male; Ovariectomy; Phenols; Piperazines; Rats; Rats, Wistar; Receptors, Serotonin; Ritanserin; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Subthalamus; Sulfonamides | 2004 |
Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.
Topics: Aminopyridines; Analysis of Variance; Animals; Citalopram; Discrimination Learning; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Indoles; Male; Phencyclidine; Piperazines; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |